Economic consequences of overweight and obesity in infertility: A framework for evaluating the costs and outcomes of fertility care

Human Reproduction Update

Volumn 16, Issue 3, 2010, Pages 246-254

  Koning, A M H ^a   Kuchenbecker, W K H ^b   Groen, H ^c   Hoek, A ^c   Land, J A ^c   Khan, K S ^d   Mol, B W J ^e  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Assisted reproduction; Body mass; Cost; Effectiveness; Infertility

Indexed keywords

GONADOTROPIN;

ANOVULATION; CALCULATION; COHORT ANALYSIS; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EVALUATION; FEMALE; FERTILITY; FERTILIZATION IN VITRO; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INFERTILITY; INFERTILITY THERAPY; INFORMATION PROCESSING; INTRAUTERINE INSEMINATION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; OBESITY; OVULATION INDUCTION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; ARTIFICIAL INSEMINATION; BODY MASS; COMPARATIVE STUDY; COST OF ILLNESS; ECONOMICS; FEMALE INFERTILITY; METHODOLOGY; PREGNANCY; STATISTICAL MODEL;

ANOVULATION; BODY MASS INDEX; COST OF ILLNESS; FEMALE; FERTILITY; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; INSEMINATION, ARTIFICIAL; MODELS, ECONOMIC; OBESITY; OVERWEIGHT; OVULATION INDUCTION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 77954502626     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmp053     Document Type: Review

References (56)

1. Al-Azemi M, Omu FE, Omu AE. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 2004;270:205-210.
2. Balen AH, Platteau P, Andersen AN, Devroey P, Sorensen P, Helmgaard L, Arce JC. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG 2006; 332:434-435.
3. Barton JR, Istwan NB, Rhea D, Collins A, Stanziano GJ. Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditions. Dis Manag 2006;9:236-241.
4. Butler D. The fertility riddle. Nature 2004;432:38-39.
5. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004;103:219-224.
6. Chen KT, Sell RL, Tuomala RE. Cost-effectiveness of elective Cesarean delivery in human immunodeficiency virus-infected women. Obstet Gynecol 2001;97:161-168.
7. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995;10:2705-2712.
8. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998; 13:1502-1505.
9. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007a;30:2070-2076.
10. Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, Curtis KM. Maternal obesity and risk of stillbirth: a meta-analysis. Am J Obstet Gynecol 2007b;3:223-228.
11. Chu SY, Kim SY, Schmid CH, Dietz PM, Callaghan WM, Lau J, Curtis KM. Maternal obesity and risk of Caesarean delivery: a meta-analysis. Obes Rev 2007c;8:385-394.
12. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338:147-152.
13. Cnossen JS, Leeflang MMG, de Haan EEM, Mol BWJ, Van der Post JAM, Khan KS, ter Riet G. Accuracy of body mass index in predicting pre-eclampsia: bivariate meta-analysis. BJOG 2007;114:1477-1485.
14. Edwards LE, Hellerstedt WL, Alton IR, Story M, Himes JH. Pregnancy complications and birth outcomes in obese and normal-weight women: effects of gestational weight change. Obstet Gynecol 1996; 87:389-394.
15. Eijkemans MJC, Polinder S, Mulders AGMGJ, Laven JSE, Habbema JDF, Fauser BCJM. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Hum Reprod 2005;20:2830-2837.
16. Esinler I, Bozdag G, Yarali H. Impact of isolated obesity on ICSI outcome. Reprod Biomed Online 2008;17:583-587.
17. Fedorcsak P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland AK, Abyholm T, Tanbo T. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004; 19:2523-2528.
18. Garbaciak JA Jr, Richter M, Miller S, Barton JJ. Maternal weight and pregnancy complications. Am J Obstet Gynecol 1985;152:238-245.
19. Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod 2007;22:414-420.
20. Gillett MJ, Putt JR, Farguhar D. Prioritising for fertility treatments-the effect of excluding women with a high body mass index. BJOG 2006; 113:1107-1109.
21. Goverde AJ, McDonnell J, Vermeiden JPM, Schats R, Rutten FFH, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 2000;355:13-18.
22. Graziosi GCM, Van der Steeg JW, Reuwer PHW, Dogtrop AP, Bruinse HW, Mol BWJ. Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Hum Reprod Update 2005;20:1067-1071.
23. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209.
24. Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 2004;82:421-429.
25. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999;84:1470-1474.
26. Imani B, Eijkemans JMC, Te Velde ER, Habbema JDF, Fauser BCJM. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocr Metab 1998;83:2361-2365.
27. Imani B, Eijkemans JMC, te Velde ER, Habbema JDF, Fauser BCJM. A normogram to predict the probability of life birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 2002;71:91-97.
28. James WP, Jackson-Leach R, Ni Mhurchu C. Overweight and Obesity (High Body Mass Index). In Lopez EAD, Rodgers A, Murray CJL, Ezzati M (eds). Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: WHO, 2004, 497-596.
29. Jensen TK, Scheike T, Keiding N, Schaumburg I, Grandjean P. Fecundability in relation to body mass and menstrual cycle patterns. Epidemiology 1999;10:422-428.
30. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;36:105-111.
31. Koloszar S, Daru J, Kereszturi A, Zavaczki Z, Szollosi J, Pal A. Effect of female body weight on efficiency of donor AI. Arch Androl 2002; 48:323-327.
32. Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher N. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG 2005;112:403-408.
33. Lashen H, Ledger W, Bernal A, Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod 1999;14:712-715.
34. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA et al.; Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin or both for polycystic ovarian syndrome. N Engl J Med. 2007;8:551-566.
35. Linné Y. Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 2004;5:137-143.
36. Lintsen AME, Pasker-De Jong PCM, De Boer EJ, Burger CW, Jansen CAM, Braat DDM, van Leeuwen FE. Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod 2005;20:1867-1875.
37. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology a systematic review. Hum Reprod Update 2007;13:433-444.
38. Maheshwari A, Scotland G, Bell J, McTavish A, Hamilton M, Bhattacharya S. The direct health services costs of providing assisted reproductive services in overweight or obese women: a retrospective corss-sectional analysis. Hum Reprod 2009;1:1-8.
39. McClure N, McQuinn B, McDonald J, Kovacs GT, Healy DL, Burger HG. Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome? Fertil steril 1992; 58:622-624.
40. Moss JR, Crowther CA, Hiller JE, Willson KJ, Robinson JS. Costs and consequences of treatment for mild gestational diabetes mellitus - evaluation from the ACHOIS randomized trial. BMC Pregnancy Childbirth 2007;7:27.
41. Mulders AGMGJ, Laven JSE, Eijkemans MJC, Hughes EG, Fauser BCJM. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta analysis. Hum Reprod Update 2003;7:50-58.
42. Norman RJ, Noakes M, Wu R, Davies MJ, Moran L, Wang JX. Improving reproductive performance in overweight/obese woman with effective weight management. Hum Reprod Update 2004;10:267-280.
43. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 2003; 9:359-372.
44. Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes 2007;14:482-487.
45. Schokker DF, Visscher TL, Nooyens AC, Van Baak MA, Seidell JC. Prevalence of overweight and obesity in the Netherlands. Obes Rev 2007;8:101-108.
46. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S. Maternal obesity and pregnancy outcome: a study of 287.213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25:1175-1182.
47. Tang T, Glanville J, Orsi N, Barth JH, Balen AH. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 2006; 21:1416-1425.
48. Usha Kiran TS, Hemmadi S, Bethel J, Evans J. Outcome of pregnancy in a women with an increased body mass index. BJOG 2005;112: 768-772.
49. Van der Steeg JW, Steures P, Eijkemans MJC, Habbema JDF, Hompes PGA, Burggraaff JM, Oosterhuis GJE, Bossuyt PMM, Van der Veen F, Mol BWJ. Obesity affects spontaneous pregnancy chances in subfertile ovulatory women. Hum Reprod 2007;23:324-328.
50. Wang JX, Davies MJ, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. Br Med J 2000;321:1320-1321.
51. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002; 10:551-554.
52. Wang JX, Warnes, Davies MJ, Norman RJ. Overweight patients have a higher fecundity than normal weight woman undergoing controlled ovarian hyperstimulation with intrauterine insemination. Fertil Steril 2004;81:1710-1712.
53. Watson R. EU aims to tackle growing problem of obesity. Br Med J 2005; 331:1426.
54. Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Carter SM, Craigo SD et al. Obesity, obstetric complications and Cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol 2004;190:1091-1097.
55. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
56. Zachariah M, Fleming R, Acharya U. Management of obese women in assisted conception units: a UK survey. Hum Fertil 2006;9:101-105.